Cellectar Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,147,880 | 3.2% |
VC/PE Firms | 3,197,394 | 8.92% |
Institutions | 5,266,249 | 14.7% |
Hedge Funds | 6,383,993 | 17.8% |
General Public | 19,853,408 | 55.4% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 191.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,671,550 | US$5.9m | 35.7% | 4.37% | |||
3,197,394 | US$5.1m | 5.31% | 2.98% | |||
2,712,443 | US$4.4m | 48% | 0.4% | |||
1,726,986 | US$2.8m | 10.4% | no data | |||
1,022,161 | US$1.6m | 49.9% | 0.34% | |||
897,605 | US$1.4m | 0% | no data | |||
847,647 | US$1.4m | 0% | 53.49% | |||
352,452 | US$567.4k | 3.3% | no data | |||
228,930 | US$368.6k | 0% | no data | |||
215,000 | US$346.2k | 0% | 0.12% | |||
164,449 | US$264.8k | 163% | no data | |||
139,231 | US$224.2k | 66.9% | no data | |||
120,497 | US$194.0k | -30% | no data | |||
116,814 | US$188.1k | 0% | no data | |||
61,094 | US$98.4k | 0% | no data | |||
55,038 | US$88.6k | 0% | no data | |||
53,141 | US$85.6k | 0% | no data | |||
53,022 | US$85.4k | -16.2% | 0.01% | |||
49,218 | US$79.2k | 0% | no data | |||
42,578 | US$68.6k | 0% | no data | |||
39,599 | US$63.8k | 0% | no data | |||
30,000 | US$48.3k | 0% | no data | |||
25,030 | US$40.3k | 0% | 0.01% | |||
23,800 | US$38.3k | 0% | no data | |||
23,169 | US$37.3k | -54.7% | no data |